Compound brief
Evidence brief. Not treatment advice or a safety clearance. Last evidence update: September 2026.
A quinolinium cation, not a peptide. The proposed enzyme target methylates nicotinamide and pulls on the NAD pool. Human exposure data were not extracted.
Forums file it beside peptides. It is a charged small molecule.
NNMT methylates nicotinamide and consumes the methyl donor S-adenosylmethionine. Inhibiting it is proposed to spare NAD-related metabolism and to change adipocyte energy use.
That chain is a hypothesis in this sheet. No human interaction study was extracted.
Forum themes are unverified. They do not outrank a study, and they are not a dose.
Small-molecule fat-loss logs · unverified
Threads treat 5-amino-1MQ as another peptide vial. It is a quinolinium salt aimed, in papers, at NNMT. Community before-and-after language is not an enzyme assay.
Theme summarized from public discussion. Not a quoted post, not a trial, and not a dose.